Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two-dose betamethasone timing for prevention of respiratory distress in preterm neonates
IRCT2015090123851N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of betamethasone in respiratory distress syndrome (RDS), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Neonatal dyspnea. Started Nov 2015; status: completed.
02
Drugs
betamethasone
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on IRCT2015090123851N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015090123851N1.